Chinese Journal of Tissue Engineering Research ›› 2010, Vol. 14 ›› Issue (11): 2072-2075.doi: 10.3969/j.issn.1673-8225.2010.11.043

Previous Articles     Next Articles

Effects of tumor necrosis factor-alpha on maturity of mouse embryonic fibroblasts

Yang Wen-jiu, Zou Yun-wen, Wang Zhi-jie   

  1. Department of Spinal Surgery, Affiliated Hospital of Qingdao University Medical College, Qingdao  266003, Shandong Province, China
  • Online:2010-03-12 Published:2010-03-12
  • Contact: Zou Yun-wen, Chief physician, Master’s supervisor, Department of Spinal Surgery, Affiliated Hospital of Qingdao University Medical College, Qingdao 266003, Shandong Province, China

Abstract:

BACKGROUND: In recent years, studies have shown the effects of tumor necrosis factor-α (TNF-α) on fibroblasts at different organizations in a tissue-specific and dose-dependent manner.
OBJECTIVE: To investigate the biologic effects of TNF-α and its signal transduction pathway-specific kinase inhibitors on mouse embryonic fibroblasts (NIH3T3).
METHODS: NIH3T3 cells were cultured in vitro, and then the cells were assigned into 3 groups. Cells in the control group were cultured in DMEM high-glucose medium with 2% serum; those in the TNF-α group were cultured in 100 μg/L TNF-α medium; those in the TNF-α+Anti-TNFRSF1B group were firstly cultured in medium with 50 μg/L Anti-TNFRSF1B for 1 hour, and then placed in the medium with 100 μg/L TNF-α. RT-PCR and Western blot methods were used to evaluate mRNA and protein expressions of type Ⅰ collagen and matrix metalloproteinase 3 (MMP3) in each group.
RESULTS AND CONCLUSION: In this experiment, NIH3T3 cells cultured with a certain concentration of TNF-α, the specificity kinase signal of transduction pathway presented with phosphorylation or protein activation, and the signal pathway was activated, which promoted MMP3 activation, and significantly reduced the expression of type Ⅰ collagen. The effect of TNF-α was certainly inhibited, but not completely eliminated after adding its signal transduction pathway inhibitor Anti-TNFRSF1B. This further proves the role of TNF-α on NIH3T3 activation.

CLC Number: